Home › Atopic Dermatitis (Eczema) › New York
Atopic Dermatitis (Eczema) clinical trials in New York
16 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in New York.
Cities in New York
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- OptiSkin Medical, New York
- Equity Medical, LLC, The Bronx
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 72 · All sexes · Updated Sep 29, 2026 · NCT06808477Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brooklyn
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Montefiore - Jacobi Dermatology Clinic, The Bronx
- Montefiore - Clinical Research Center, The Bronx
- Montefiore - Greene Medical Arts Pavillion, The Bronx
- and 2 more
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 25, 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
Recruiting
Ages 13 to 17 · All sexes · Updated Sep 8, 2026 · NCT07746427A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Sadick Research Group, LLC, New York
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Skin Microbial Ecology in Atopic Dermatitis
- University of Rochester Medical Center, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 13 and older · All sexes · Updated Jul 14, 2026 · NCT04170244A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
RecruitingPhase 3
Ages 18 to 63 · All sexes · Updated Jul 6, 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
- University of Rochester Medical Center: Department of Dermatology, Rochester
RecruitingPhase 1
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Empire Dermatology, East Syracuse
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - Site 7080, Auburn
- Galderma Investigational Site # 7052, East Syracuse
- Galderma Investigational Site - 8282, Mount Kisco
- and 3 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RecruitingObservational studyHealthy volunteers welcome
Up to age 99 · All sexes · Updated Feb 4, 2026 · NCT05584488Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Feb 2, 2026 · NCT07242638A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Pfizer, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 0 and older · Women · Updated Dec 9, 2025 · NCT05721937From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.